3,702
Views
5
CrossRef citations to date
0
Altmetric
Review

Public health impact of pneumococcal conjugate vaccination: a review of measurement challenges

ORCID Icon, ORCID Icon, ORCID Icon, , &
Pages 1291-1309 | Received 03 Jun 2021, Accepted 19 Aug 2021, Published online: 11 Sep 2021

Figures & data

Figure 1. Example illustration of herd protection among unvaccinated individuals

* Illustrative using population data from Germany [Citation36]. M, million.
Figure 1. Example illustration of herd protection among unvaccinated individuals

Figure 2. Illustration of vaccine preventable and non-vaccine preventable noninvasive pneumococcal disease (all-cause pneumonia or all-cause otitis media)

OM, otitis media; S. pneumoniae, Streptococcus pneumoniae.
Figure 2. Illustration of vaccine preventable and non-vaccine preventable noninvasive pneumococcal disease (all-cause pneumonia or all-cause otitis media)

Figure 3. Estimated public health impact of PCV13 vaccination among adults globally, 2010–2019

* Vaccine-type = serotypes included in PCV13. Range of outcomes averted based on number needed to vaccinate (NNV) and doses assumed to be administered to adults. CAP, community acquired pneumonia; ICU, intensive care unit; IPD, invasive pneumococcal disease.
Figure 3. Estimated public health impact of PCV13 vaccination among adults globally, 2010–2019
Supplemental material

Supplemental Material

Download MS Word (58.1 KB)